-
1,3-bis(4-amino-2-methylquinolin-6-yl)urea hydrate
-
ChemBase ID:
154748
-
Molecular Formular:
C21H22N6O2
-
Molecular Mass:
390.43838
-
Monoisotopic Mass:
390.18042397
-
SMILES and InChIs
SMILES:
Cc1cc(c2cc(ccc2n1)NC(=O)Nc1ccc2c(c1)c(cc(n2)C)N)N.O
Canonical SMILES:
O=C(Nc1ccc2c(c1)c(N)cc(n2)C)Nc1ccc2c(c1)c(N)cc(n2)C.O
InChI:
InChI=1S/C21H20N6O.H2O/c1-11-7-17(22)15-9-13(3-5-19(15)24-11)26-21(28)27-14-4-6-20-16(10-14)18(23)8-12(2)25-20;/h3-10H,1-2H3,(H2,22,24)(H2,23,25)(H2,26,27,28);1H2
InChIKey:
UXYZYUHSZVKWTR-UHFFFAOYSA-N
-
Cite this record
CBID:154748 http://www.chembase.cn/molecule-154748.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
1,3-bis(4-amino-2-methylquinolin-6-yl)urea hydrate
|
|
|
|
|
IUPAC Traditional name
|
|
aminoquinuride dihydrochloride hydrate
|
|
|
|
|
Synonyms
|
|
1,3-Bis(4-amino-2-methyl-6-quinolyl)urea hydrate
|
|
Aminokinuride
|
|
Aminoquincarbamide
|
|
Aminoquinuride
|
|
N,N′-Bis(4-amino-2-methyl-6-quinolyl)urea
|
|
NSC 12155
|
|
Surfen hydrate
|
|
(bis-2-methyl-4-amino-quinolyl-6-carbamide hydrate
|
|
Aminoquinuride
|
|
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
11.518541
|
H Acceptors
|
5
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-1.5478865
|
LogD (pH = 7.4)
|
-0.4782081
|
Log P
|
2.038853
|
Molar Refractivity
|
112.4792 cm3
|
Polarizability
|
43.13769 Å3
|
Polar Surface Area
|
118.95 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
S6951
|
Biochem/physiol Actions Surfen is a heparan sulfate antagonist, originally developed in the late thirties as an excipient for the production of depot insulin. Heparan sulfate (HS) is structurally related to heparin but contains fewer sulfate groups per disaccharide, and it exists almost exclusively attached to protein cores of proteoglycans, which cells either display on the plasma membrane or secrete into the extracellular matrix. Surfen binds to the chains of glycosaminoglycan (GAG)/HS and prevents binding of the enzymes and proteins thus act as HS antagonist. Surfen is more potent than protamine, a clinically used heparin antagonist. |
PATENTS
PATENTS
PubChem Patent
Google Patent